Thomas Hancock
Director/Board Member bei A&G Pharmaceutical, Inc.
Profil
Thomas Edwin Hancock is currently a Director at Spectra Analysis Instruments, Inc., A&G Pharmaceutical, Inc., Cequent Pharmaceuticals, Inc., Nexus Medical LLC, and Magellan Biosciences, Inc. He previously worked as a Managing Director at U.S.
Bancorp, Managing Director & Senior Equity Analyst at Piper Sandler & Co. (Broker), Director at Stheno Corp., Director at Pacira CryoTech, Inc., Independent Director at Kiora Pharmaceuticals, Inc., Director at PathoLase, Inc., Finance Director at New England Partners, Research Scientist at COR Therapeutics, Inc., Principal at Genentech, Inc., Analyst at Bank of America Corp., Senior Analyst at Piper Sandler & Co. (Broker), Secretary & Vice President-Business Development at Geneva Acquisition Corp., Senior Analyst at Leerink Partners LLC, and Senior Research Associate at NationsBanc Montgomery Securities LLC.
He received his undergraduate and MBA degrees from the University of California, Berkeley.
Aktive Positionen von Thomas Hancock
Unternehmen | Position | Beginn |
---|---|---|
A&G Pharmaceutical, Inc.
A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Director/Board Member | - |
Nexus Medical LLC
Nexus Medical LLC Investment ManagersFinance Nexus Medical LLC(Nexus Medical) is a Venture Capital firm founded in 1996 by Edwin Snape and John F. Rousseau. The firm is headquartered in Quincy, Massachusetts. | Private Equity Investor | 01.01.1996 |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Director/Board Member | - |
Spectra Analysis Instruments, Inc.
Spectra Analysis Instruments, Inc. Miscellaneous Commercial ServicesCommercial Services Spectra Analysis Instruments, Inc. supplies molecular spectroscopy systems and applications for chromatography. The company was founded by George J. Giansanti, William W. Carson and Sydney Bourne in 1993 and is headquartered in Marlborough, MA. | Director/Board Member | - |
Magellan Biosciences, Inc.
Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Magellan Biosciences, Inc. engages in the manufacture of medical devices for point-of-care systems, clinical laboratory instruments, and analytical laboratory. The company was founded on May 4, 2005 and is headquartered in North Billerica, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Thomas Hancock
Unternehmen | Position | Ende |
---|---|---|
KIORA PHARMACEUTICALS, INC. | Director/Board Member | 01.04.2021 |
Stheno Corp.
Stheno Corp. Medical SpecialtiesHealth Technology Stheno Corp. develops non contact chemical detectors and detection systems for the pharmaceutical industry. The firm commercializes a chemical-detection technology to find impurities in pharmaceutical processing and production line. The company was founded by Phillip R. Gibbs and William Edens on June 24, 2003 and is headquartered in Atlanta, GA. | Director/Board Member | 25.02.2010 |
Geneva Acquisition Corp.
Geneva Acquisition Corp. Financial ConglomeratesFinance The Company's principal activity is to identify a manufacturing or distributing products or specialty materials business to, or provides services within, the healthcare sector, as well as other sectors within the experience and competencies of the management team. Its product may includes medical devices used in cardiovascular, orthopedic, gynecological, urological, metabolic disease and neurovascular applications, medical devices used in drug delivery, vitro and in vivo diagnostic testing equipment and reagents,analytical instruments and related consumables used in drug development, imaging equipment and contrast agents and information technology applications. | Corporate Secretary | 10.03.2009 |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology. | Analyst-Equity | 03.09.2003 |
░░░░░ ░░░░░░░ ░░░░░ ░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Thomas Hancock
University of California, Berkeley | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
US BANCORP | Finance |
KIORA PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 15 |
---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology. | Finance |
Stheno Corp.
Stheno Corp. Medical SpecialtiesHealth Technology Stheno Corp. develops non contact chemical detectors and detection systems for the pharmaceutical industry. The firm commercializes a chemical-detection technology to find impurities in pharmaceutical processing and production line. The company was founded by Phillip R. Gibbs and William Edens on June 24, 2003 and is headquartered in Atlanta, GA. | Health Technology |
Spectra Analysis Instruments, Inc.
Spectra Analysis Instruments, Inc. Miscellaneous Commercial ServicesCommercial Services Spectra Analysis Instruments, Inc. supplies molecular spectroscopy systems and applications for chromatography. The company was founded by George J. Giansanti, William W. Carson and Sydney Bourne in 1993 and is headquartered in Marlborough, MA. | Commercial Services |
A&G Pharmaceutical, Inc.
A&G Pharmaceutical, Inc. BiotechnologyHealth Technology A&G Pharmaceutical, Inc. develops and creates monoclonal antibodies to cancer-specific targets. It focuses on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis and treatment of breast cancer. The firm's product Theranostics develops molecular diagnostic tests in tandem with targeted therapeutics. The company was founded by Jun Hayashi, Ginette Serrero, and Gordon H. Sato in June 2000 and is headquartered in Columbia, MD. | Health Technology |
Pacira CryoTech, Inc.
Pacira CryoTech, Inc. Medical/Nursing ServicesHealth Services Pacira Cryotech, Inc. develops novel technologies for treatment of peripheral nerves. Its iovera treatment harnesses the power of cold with the Focused Cold Therapy delivery system and delivers immediate results for both therapeutic and aesthetic applications. The firm’s iovera treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The company was founded by Lisa Elkins in 2005 and is headquartered in Fremont, CA. | Health Services |
Geneva Acquisition Corp.
Geneva Acquisition Corp. Financial ConglomeratesFinance The Company's principal activity is to identify a manufacturing or distributing products or specialty materials business to, or provides services within, the healthcare sector, as well as other sectors within the experience and competencies of the management team. Its product may includes medical devices used in cardiovascular, orthopedic, gynecological, urological, metabolic disease and neurovascular applications, medical devices used in drug delivery, vitro and in vivo diagnostic testing equipment and reagents,analytical instruments and related consumables used in drug development, imaging equipment and contrast agents and information technology applications. | Finance |
PathoLase, Inc.
PathoLase, Inc. Medical SpecialtiesHealth Technology PathoLase, Inc. developed light-based disinfectant devices and procedures. It offered laser technology solutions that used to address a series of medical issues, from toenail fungus and periodontal disease to more serious life threatening problems, such as blood borne and respiratory infections. The company was founded by John Strisower in 2004 and was headquartered in Chico, CA. | Health Technology |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
NationsBanc Montgomery Securities LLC | Finance |
New England Partners
New England Partners Investment ManagersFinance Founded in 1992, New England Partners LP (NEP) is a venture capital firm. The firm is headquartered in Boston, Massachusetts. | Finance |
Nexus Medical LLC
Nexus Medical LLC Investment ManagersFinance Nexus Medical LLC(Nexus Medical) is a Venture Capital firm founded in 1996 by Edwin Snape and John F. Rousseau. The firm is headquartered in Quincy, Massachusetts. | Finance |
Magellan Biosciences, Inc.
Magellan Biosciences, Inc. Medical SpecialtiesHealth Technology Magellan Biosciences, Inc. engages in the manufacture of medical devices for point-of-care systems, clinical laboratory instruments, and analytical laboratory. The company was founded on May 4, 2005 and is headquartered in North Billerica, MA. | Health Technology |